Mirum Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
Good afternoon, everyone. I'm Lisa Walter, Biotech Analyst here at RBC Capital Markets. Thanks for joining us at RBC's 2026 Global Healthcare Conference.
This session, we have Mirum Pharmaceuticals, and we have the pleasure of hosting Peter Radovich, President and COO, as well as Andrew McKibben, Senior VP, Strategic Finance and Investor Relations. Peter, Andrew, thanks so much for joining us today. How are you both doing?
Doing great, Lisa. Thanks for having us. Great to be here.
Well, it's a pleasure to have you here today. Maybe just to kick things off, can you give us a big picture overview of where Miriam stands today?
There's been two clinical data readouts recently. You have an impressive portfolio, three approved assets in rare liver disease, and multiple pipeline assets as well that are brewing. So can you walk us
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
